[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results in 2021

Roche anticipates sales of COVID-19 medicines and diagnostics to decrease by approximately CHF 2 billion to around CHF 5 billion, and sales losses to biosimilars in the current year to be roughly CHF 2.5 billion.
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news